Drawing for COLOSTAT

USPTO serial 79220096

COLOSTAT

Reviewed by CopyMark Law Group

Reg. 6044427Status 700Renewal
Filing date
Status date
Registration date
May 5, 2020
Examiner
BRADLEY, EVELYN
Law office
POST REGISTRATION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with COLOSTAT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,275

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles G. Zug

CHARLES G ZUG NELSON MULLINS RILEY & SCARBOROUGH LLP1320 MAIN STREET 17TH FLOORCOLUMBIA, SC 29201UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005[ Biochemical preparations for medical and pharmaceutical use, specifically for cancer or neoplasia; ] biochemical diagnostic preparations for medical purposes; chemical diagnostic reagents for medical use; chemical diagnostic preparations for medical use [ ; diagnostic agents for pharmaceutical use being medical diagnostic reagents; ] diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical use sold in kit form; diagnostic preparations for medical purposes; diagnostic reagents for medical use; diagnostic reagents for medical use sold in kit form; diagnostic substances for medical use; medical diagnostic test strips for cancer or neoplasia detection; cartridges sold prefilled with diagnostic agents for cancer or neoplasia detection; reagents for use in diagnostic tests for medical purposes; reagents for analytical purposes for medical purposes; reagents for medical use; diagnostic reagents for medical purposes; none of the foregoing being in the nature of pharmaceuticalsACTIVE—
010Apparatus for carrying-out diagnostic tests for medical purposes, namely, immunoassay apparatus, molecular apparatus, isoelectric focussing apparatus, SDS/PAGE apparatus, flow cytometry apparatus, mass spectrometry apparatus, MALDI-TOF apparatus, biosensor technology apparatus, evanescent fibre optic apparatus and fluorescence resonance energy transfer apparatus all for the detection of cancer or neoplasia; apparatus for diagnostic purposes, namely, medical diagnostic apparatus for detecting cancer or neoplasia; apparatus for medical diagnostic purposes, namely, immunoassay apparatus, molecular apparatus, isoelectric focussing apparatus, SDS/PAGE apparatus, flow cytometry apparatus, mass spectrometry apparatus, MALDI-TOF apparatus, biosensor technology apparatus, evanescent fibre optic apparatus and fluorescence resonance energy transfer apparatus for medical diagnostic use all for the detection of cancer or neoplasia; apparatus sold in kit form for medical diagnostic purposes, namely, diagnostic kits consisting primarily of probes, buffers and reagents for use in testing bodily fluids and bodily biological materials including blood, tissue and stool; diagnostic apparatus for medical purposes, namely, diagnostic kits consisting primarily of probes, buffers and reagents for use in liquid or tissue biopsy testing; diagnostic test kits for the detection of haemoglobin in faeces; medical apparatus for diagnostic purposes for the detection of cancer or neoplasia; medical diagnostic apparatus sold in kit form, namely, diagnostic kits consisting primarily of probes, buffers and reagents for use in testing bodily fluids and bodily biological materials, including blood, tissue and stool; medical diagnostic testing apparatus, namely, medical diagnostic testing apparatus for bodily fluids and bodily biological materials, including blood, tissue and stool; medical electronic diagnostic apparatus, namely, medical electronic diagnostic apparatus for testing bodily fluids and bodily biological materials including blood, tissue and stool; scientific apparatus for medical diagnostic purposes for testing bodily fluids and bodily biological materials including blood, tissue and stool; tools for medical diagnostics, namely, immunoassay apparatus, molecular apparatus, isoelectric focussing apparatus, SDS/PAGE apparatus, flow cytometry apparatus, mass spectrometry apparatus, MALDI-TOF apparatus, biosensor technology apparatus, evanescent fibre optic apparatus and fluorescence resonance energy transfer apparatus for testing bodily fluids and bodily biological materials including blood, tissue and stool; medical apparatus instruments, namely, namely, immunoassay apparatus, molecular apparatus, isoelectric focussing apparatus, SDS/PAGE apparatus, flow cytometry apparatus, mass spectrometry apparatus, MALDI-TOF apparatus, biosensor technology apparatus, evanescent fibre optic apparatus and fluorescence resonance energy transfer apparatus for testing bodily fluids and bodily biological materials including blood, tissue and stool; in vitro diagnostic testing apparatus for medical use for the detection of cancer or neoplasiaACTIVE—
044Medical testing and analysis for diagnostic purposes; surgical diagnostic services; providing medical information; medical services; medical treatment and medical diagnostic testing services; genetic testing services for medical purposes; medical screening services; health screening services in the field of cancer and neoplasia; medical advisory services relating to disease including providing disease risk assessment and related informationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 5, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 26, 2022INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Dec 11, 2021INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Apr 12, 2021LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Apr 11, 2021COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Apr 11, 2021PLGLASSIGNED TO PARALEGAL—
Feb 28, 2021LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Oct 3, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 11, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 11, 2020FIMPFINAL DISPOSITION PROCESSED—
Aug 5, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 5, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 1, 2020TMBNTTAB RELEASE CASE TO TRADEMARKS—
Apr 1, 2020OP.TOPPOSITION TERMINATED NO. 999999—
Apr 1, 2020OP.DOPPOSITION DISMISSED NO. 999999—
May 10, 2019RFNPREFUSAL PROCESSED BY IB—
Apr 24, 2019OP.IOPPOSITION INSTITUTED NO. 999999—
Apr 19, 2019OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 17, 2019OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Apr 17, 2019OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Apr 16, 2019OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Apr 3, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 3, 2019OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 19, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 19, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 15, 2019GPNXNOTIFICATION PROCESSED BY IB—
Feb 27, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 27, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 27, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 14, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 11, 2019ALIEASSIGNED TO LIE—
Jan 28, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 23, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Jan 23, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 23, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 23, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 7, 2018LIMELIMITATION FROM THE IB - REQUEST EXAM REVIEW—
Nov 2, 2018LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Aug 4, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 4, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 4, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 29, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 28, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 28, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 3, 2018RFNTREFUSAL PROCESSED BY IB—
Jan 13, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 13, 2018RFRRREFUSAL PROCESSED BY MPU—
Dec 30, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 29, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 25, 2017DOCKASSIGNED TO EXAMINER—
Nov 11, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 7, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 2, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance